Three Bearings Fiduciary Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31K Hold
40
﹤0.01% 205
2026
Q1
$2.43K Hold
40
﹤0.01% 201
2025
Q4
$2.23K Buy
+40
New +$1.92K ﹤0.01% 223

Other funds holding BMY

Three Bearings Fiduciary Advisors's BMY Position: Q2 2026 in Review

Three Bearings Fiduciary Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 40 shares worth $2.31K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Three Bearings Fiduciary Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.43K in Q1 2026. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Three Bearings Fiduciary Advisors held 40 shares of Bristol-Myers Squibb worth $2.31K as of Q2 2026.
  • Three Bearings Fiduciary Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Three Bearings Fiduciary Advisors's portfolio in Q2 2026, its #205 holding.
  • Three Bearings Fiduciary Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Three Bearings Fiduciary Advisors's Bristol-Myers Squibb position peaked at $2.43K in Q1 2026.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Three Bearings Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.